Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 800

1.

Genetic polymorphisms of autophagy-related gene 5 (ATG5) rs473543 predict different disease-free survivals of triple-negative breast cancer patients receiving anthracycline- and/or taxane-based adjuvant chemotherapy.

Li M, Ma F, Wang J, Li Q, Zhang P, Yuan P, Luo Y, Cai R, Fan Y, Chen S, Li Q, Xu B.

Chin J Cancer. 2018 Jan 31;37(1):4. doi: 10.1186/s40880-018-0268-1.

2.

Computed tomography and magnetic resonance imaging evaluation of pelvic lymph node metastasis in bladder cancer.

Li Y, Diao F, Shi S, Li K, Zhu W, Wu S, Lin T.

Chin J Cancer. 2018 Jan 26;37(1):3. doi: 10.1186/s40880-018-0269-0.

3.
4.

Follistatin-like protein 1 plays a tumor suppressor role in clear-cell renal cell carcinoma.

Liu Y, Tan X, Liu W, Chen X, Hou X, Shen D, Ding Y, Yin J, Wang L, Zhang H, Yu Y, Hou J, Thompson TC, Cao G.

Chin J Cancer. 2018 Jan 22;37(1):2. doi: 10.1186/s40880-018-0267-2.

5.

Prognostic values of the integrated model incorporating the volume of metastatic regional cervical lymph node and pretreatment serum Epstein-Barr virus DNA copy number in predicting distant metastasis in patients with N1 nasopharyngeal carcinoma.

Yao JJ, Zhou GQ, Wang YQ, Wang SY, Zhang WJ, Jin YN, Zhang F, Li L, Liu LZ, Cheng ZB, Ma J, Qi ZY, Sun Y.

Chin J Cancer. 2017 Dec 29;36(1):98. doi: 10.1186/s40880-017-0264-x.

6.

Famitinib versus placebo in the treatment of refractory metastatic colorectal cancer: a multicenter, randomized, double-blinded, placebo-controlled, phase II clinical trial.

Xu RH, Shen L, Wang KM, Wu G, Shi CM, Ding KF, Lin LZ, Wang JW, Xiong JP, Wu CP, Li J, Liu YP, Wang D, Ba Y, Feng JP, Bai YX, Bi JW, Ma LW, Lei J, Yang Q, Yu H.

Chin J Cancer. 2017 Dec 22;36(1):97. doi: 10.1186/s40880-017-0263-y.

7.

Prognostic value of preoperative prognostic nutritional index and its associations with systemic inflammatory response markers in patients with stage III colon cancer.

Peng J, Zhang R, Zhao Y, Wu X, Chen G, Wan D, Lu Z, Pan Z.

Chin J Cancer. 2017 Dec 21;36(1):96. doi: 10.1186/s40880-017-0260-1.

8.

Significant value of 18F-FDG-PET/CT in diagnosing small cervical lymph node metastases in patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy.

Peng H, Chen L, Tang LL, Li WF, Mao YP, Guo R, Zhang Y, Liu LZ, Tian L, Zhang X, Lin XP, Guo Y, Sun Y, Ma J.

Chin J Cancer. 2017 Dec 19;36(1):95. doi: 10.1186/s40880-017-0265-9.

9.

Expression and clinical value of programmed cell death-ligand 1 (PD-L1) in diffuse large B cell lymphoma: a retrospective study.

Hu LY, Xu XL, Rao HL, Chen J, Lai RC, Huang HQ, Jiang WQ, Lin TY, Xia ZJ, Cai QQ.

Chin J Cancer. 2017 Dec 16;36(1):94. doi: 10.1186/s40880-017-0262-z.

10.

Survival and prognostic factors of non-small cell lung cancer patients with postoperative locoregional recurrence treated with radical radiotherapy.

Ma L, Qiu B, Zhang J, Li QW, Wang B, Zhang XH, Qiang MY, Chen ZL, Guo SP, Liu H.

Chin J Cancer. 2017 Dec 11;36(1):93. doi: 10.1186/s40880-017-0261-0.

12.

The 150 most important questions in cancer research and clinical oncology series: questions 76-85 : Edited by Chinese Journal of Cancer.

Editorial Office of Chinese Journal of Cancer.

Chin J Cancer. 2017 Nov 20;36(1):91. doi: 10.1186/s40880-017-0259-7.

13.

Expression of voltage-gated sodium channel Nav1.5 in non-metastatic colon cancer and its associations with estrogen receptor (ER)-β expression and clinical outcomes.

Peng J, Ou Q, Wu X, Zhang R, Zhao Q, Jiang W, Lu Z, Wan D, Pan Z, Fang Y.

Chin J Cancer. 2017 Nov 9;36(1):89. doi: 10.1186/s40880-017-0253-0.

14.

Nasopharyngeal carcinoma incidence and mortality in China, 2013.

Wei KR, Zheng RS, Zhang SW, Liang ZH, Li ZM, Chen WQ.

Chin J Cancer. 2017 Nov 9;36(1):90. doi: 10.1186/s40880-017-0257-9.

15.

Systematic analyses of glutamine and glutamate metabolisms across different cancer types.

Tian Y, Du W, Cao S, Wu Y, Dong N, Wang Y, Xu Y.

Chin J Cancer. 2017 Nov 7;36(1):88. doi: 10.1186/s40880-017-0255-y.

16.

Prognostic value of plasma Epstein-Barr virus DNA level during posttreatment follow-up in the patients with nasopharyngeal carcinoma having undergone intensity-modulated radiotherapy.

Li WF, Zhang Y, Huang XB, Du XJ, Tang LL, Chen L, Peng H, Guo R, Sun Y, Ma J.

Chin J Cancer. 2017 Nov 7;36(1):87. doi: 10.1186/s40880-017-0256-x.

17.
18.

Conditional survival in patients with gallbladder cancer.

Kim YJ, Kim K.

Chin J Cancer. 2017 Oct 30;36(1):85. doi: 10.1186/s40880-017-0252-1.

19.

The influence of stage at diagnosis and molecular subtype on breast cancer patient survival: a hospital-based multi-center study.

Zuo T, Zeng H, Li H, Liu S, Yang L, Xia C, Zheng R, Ma F, Liu L, Wang N, Xuan L, Chen W.

Chin J Cancer. 2017 Oct 25;36(1):84. doi: 10.1186/s40880-017-0250-3.

20.

Hepatic artery infusion chemotherapy using mFOLFOX versus transarterial chemoembolization for massive unresectable hepatocellular carcinoma: a prospective non-randomized study.

He MK, Le Y, Li QJ, Yu ZS, Li SH, Wei W, Guo RP, Shi M.

Chin J Cancer. 2017 Oct 23;36(1):83. doi: 10.1186/s40880-017-0251-2.

Supplemental Content

Loading ...
Support Center